Lower extremity arterial disease
Lower Limbs Arterial Disease (LEAD) affects over 40 million people in Europe and appears to be 2-4 times more prevalent in people with type 2 diabetes (PWT2D) than in the general population.
Pier Luigi Antignani
doaj +1 more source
Parental Intermittent Claudication as Risk Factor for Claudication in Adults [PDF]
Little is known about the familial aggregation of intermittent claudication (IC). Our objective was to examine whether parental IC increased the risk of IC in adult offspring, independent of the established cardiovascular risk factors. We evaluated the Offspring Cohort Participants of the Framingham Heart Study who were ≥30 years old, cardiovascular ...
Prushik, Scott G.+6 more
openaire +7 more sources
Transcutaneous calf-muscle electro-stimulation : a prospective treatment for diabetic claudicants? [PDF]
Background: First-line therapy for claudicants with diabetes include supervised exercise programmes to improve walking distance. However, exercise comes with a number of barriers and may be contraindicated in certain conditions. The aim of this study was
Ellul, Christian, Gatt, Alfred
core +1 more source
Naftidrofuryl for intermittent claudication [PDF]
Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive agents (Anatomic Therapeutic Chemical Classification (ATC) for medicines from the World Health Organisation class CO4A) is controversial.To evaluate evidence on the efficacy and safety of oral ...
Luc M. Van Bortel+4 more
openaire +4 more sources
Des nouveau-nés malformés et un roi boiteux : histoires Spartiates
The study of deformities and disabilities in Sparta immediately raises the issue of sources: there is no appropriate Spartan documentation dealing with this subject. The little insight on this subject comes from an assortment of texts written between the
Jeannine Boëldieu-Trevet
doaj +1 more source
Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program [PDF]
Background: Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudication (IC) contributes to poorer disease outcomes.
Abaraogu, Ukachukwu+7 more
core +5 more sources
Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui+4 more
core +1 more source
Introduction: Leriche syndrome is an aortoiliac occlusive disease caused by atherosclerotic occlusion. We report a case of Leriche syndrome with a fracture that was suspected as complex regional pain syndrome (CRPS), as the post-traumatic pain gradually ...
Byeong-Cheol Lee+8 more
doaj +1 more source
Dynamic muscle quality of the plantar flexors is impaired in claudicant patients with peripheral arterial disease and associated with poorer walking endurance [PDF]
Objective Peripheral arterial disease and intermittent claudication (PAD-IC) negatively affects physical activity and function. There is evidence for plantarflexor muscle dysfunction and weakness; however, the extent to which this dysfunction can be ...
King, Stephanie+2 more
core +1 more source
Exercise oximetry in arterial claudication
Transcutaneous oxygen pressure measurement (TcPO2) is well known as a useful tool for the evaluation of critical limb ischemia, but it is rarely used during exercise (Ex-TcPO2).
Pierre Abraham+5 more
doaj +1 more source